Health
How Generative AI is Compressing the Decades-Long Drug Discovery Timeline
Recent clinical evidence shows that artificial intelligence can reduce the early drug discovery phase from years to months, as demonstrated by a novel pulmonary fibrosis treatment. While human clinical trials remain essential, AI models like AlphaFold and generative chemistry platforms are significantly accelerating target identification and molecular design.